BC-1901S
Product Specifications
CAS Number
1358617-36-3
Target
Nrf2|||E1/E2/E3 Enzyme
Related Pathways
Immunology/Inflammation|||Ubiquitination
Bioactivity
BC-1901S functions as a proteasome-independent activator and stabilizer of NRF2. By binding to DCAF1 (E3 ligase subunit), it disrupts the NRF2/DCAF1 interaction and activates NRF2 through the inhibition of NRF2 ubiquitination, independent of KEAP1. BC-1901S has demonstrated anti-inflammatory effects in a murine model of LPS-induced acute lung injury.
Smiles
O=C(NC1=CC=C(F)C(Cl)=C1)C2CCN(C3=NC(=NC=C3)C=4C=CC=C(C4)C)CC2
Molecular Formula
C23H22ClFN4O
Molecular Weight
424.9
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6485380-01 0.1 mL
LMTK2 (Lemur Tyrosine Kinase 2, LMR2, Apoptosis-associated Tyrosine Kinase 2, AATYK2, Brain-enriched Kinase, BREK, hBREK, CDK5/p35-regulated Kinase, CPRK, FLJ46659, KIAA1079, Kinase/phosphatase/inhibitor 2, KPI2, KPI-2, Serine/threonine-protein Kinase LMT
Ask
View Details 
MBS6485380-02 5x 0.1 mL
LMTK2 (Lemur Tyrosine Kinase 2, LMR2, Apoptosis-associated Tyrosine Kinase 2, AATYK2, Brain-enriched Kinase, BREK, hBREK, CDK5/p35-regulated Kinase, CPRK, FLJ46659, KIAA1079, Kinase/phosphatase/inhibitor 2, KPI2, KPI-2, Serine/threonine-protein Kinase LMT
Ask
View Details 